Shoppers Drug Mart Corp

SC-T

0.00
0.00 (0.00%)
This company is not ACTIVE.

Analysis and Opinions about SC-T

Signal
Opinion
Expert
DON'T BUY
DON'T BUY
April 24, 2012
(Market Call Minute) In a transition. Battles last year with Ontario government. Difficult to see how they can grow the business like in the last 5 years.
Show full opinionHide full opinion
(Market Call Minute) In a transition. Battles last year with Ontario government. Difficult to see how they can grow the business like in the last 5 years.
DON'T BUY
DON'T BUY
March 30, 2012
Even though Target will create competition, he does not think it is a takeover target. They will be hurt by more US competition. Decent dividend but being assaulted on all sides by competition and government regulations.
Show full opinionHide full opinion
Even though Target will create competition, he does not think it is a takeover target. They will be hurt by more US competition. Decent dividend but being assaulted on all sides by competition and government regulations.
WEAK BUY
WEAK BUY
March 23, 2012
Is a stable stock, stays near $50. No news, but is up. Expects a pullback but if stock can break above $49. If it can make another dollar or two it might be worth an investment.
Show full opinionHide full opinion
Is a stable stock, stays near $50. No news, but is up. Expects a pullback but if stock can break above $49. If it can make another dollar or two it might be worth an investment.
PAST TOP PICK
PAST TOP PICK
February 23, 2012
(Top Pick Feb 23/11, Up 6.96%)
Show full opinionHide full opinion
(Top Pick Feb 23/11, Up 6.96%)
BUY
BUY
February 21, 2012
(Market Call Minute.) Raising dividends and cash flow is tremendous. Hated by the street, but buy for the long-term.
Show full opinionHide full opinion
(Market Call Minute.) Raising dividends and cash flow is tremendous. Hated by the street, but buy for the long-term.
DON'T BUY
DON'T BUY
February 17, 2012
Ontario legislation on generic drugs was a real blow to the company. Would take a look at this if it got back into the low $30's range.
Show full opinionHide full opinion
Ontario legislation on generic drugs was a real blow to the company. Would take a look at this if it got back into the low $30's range.
BUY
BUY
February 2, 2012
Ended year well, one of the better performing stocks on the TSX. Pulled back on news of target’s announcement of expanding into Canada with pharmacies in their stores. Looking at 13-14% earnings growth. Take advantage of dip.
Show full opinionHide full opinion
Ended year well, one of the better performing stocks on the TSX. Pulled back on news of target’s announcement of expanding into Canada with pharmacies in their stores. Looking at 13-14% earnings growth. Take advantage of dip.
Don Lato

Unlock Ratings

Price
$40.200
Owned
Unknown
DON'T BUY
DON'T BUY
December 16, 2011
There is too much competition. Everyone is getting into everyone else's business. Thinks there is going to be continuing pressure on all avenues of retail.
Show full opinionHide full opinion
There is too much competition. Everyone is getting into everyone else's business. Thinks there is going to be continuing pressure on all avenues of retail.
PAST TOP PICK
PAST TOP PICK
November 30, 2011
(A Top Pick Sept 22/11. Up 3.11%.)
Show full opinionHide full opinion
(A Top Pick Sept 22/11. Up 3.11%.)
HOLD
HOLD
October 25, 2011
There is more colour coming on this in the month of November. Good margins in the from store and they are having some growth. Not inexpensive. He would focus on discount retail.
Show full opinionHide full opinion
There is more colour coming on this in the month of November. Good margins in the from store and they are having some growth. Not inexpensive. He would focus on discount retail.
TOP PICK
TOP PICK
September 22, 2011
[Program signal failed in Sept. Also the web site did not record a clip for top picks. No opinions were recorded for Top Picks. This item was inserted on Nov 30/11.]
Show full opinionHide full opinion
[Program signal failed in Sept. Also the web site did not record a clip for top picks. No opinions were recorded for Top Picks. This item was inserted on Nov 30/11.]
DON'T BUY
DON'T BUY
August 19, 2011
Safe in this type of environment because of study earnings, but finds the valuations somewhat rich at a 13 multiple. Growth is slow down a little because of drug legislation.
Show full opinionHide full opinion
Safe in this type of environment because of study earnings, but finds the valuations somewhat rich at a 13 multiple. Growth is slow down a little because of drug legislation.
DON'T BUY
DON'T BUY
August 19, 2011
The problem here is more political than it is pricing. He sold his holdings some time ago until he could get a clearer picture of where the government regulations where to go on the pricing of drugs. Also yield is not high enough to attract him.
Show full opinionHide full opinion
The problem here is more political than it is pricing. He sold his holdings some time ago until he could get a clearer picture of where the government regulations where to go on the pricing of drugs. Also yield is not high enough to attract him.
BUY
BUY
August 10, 2011
Hasn't like this one for 4 or 5 years. Got cheaper with the Ontario rule changes and is looking better. Front store sales are really doing well. And be surprised to see it in the mid-$40's in the next 8-12 months.
Show full opinionHide full opinion
Hasn't like this one for 4 or 5 years. Got cheaper with the Ontario rule changes and is looking better. Front store sales are really doing well. And be surprised to see it in the mid-$40's in the next 8-12 months.
DON'T BUY
DON'T BUY
July 26, 2011
Loblaws (L-T) or Shoppers (SC-T)? Doesn't particularly like either of them. If he had to pick one he would give the benefit of the doubt to Shoppers.
Show full opinionHide full opinion
Loblaws (L-T) or Shoppers (SC-T)? Doesn't particularly like either of them. If he had to pick one he would give the benefit of the doubt to Shoppers.
Showing 46 to 60 of 452 entries